Fc Mutagenesis
Fc Mutagenesis is a targeted engineering methodology involving the systematic alteration of amino acid residues within the crystallizable fragment (Fc) region of an antibody to modulate its effector functions, stability, and pharmacokinetic properties while preserving structural integrity.
24
Publications
2.2K
Citations
186
Authors
55
Institutions
Publications per year
2017–2026
7
Parents
24
1–5 of 24
186
The University of Texas Southwestern Medical Center, United States
3 publications · 681 citations
3
h-index
3
h-index
2
h-index
2
h-index
The University of Texas Southwestern Medical Center, United States
2 publications · 314 citations
2
h-index
1–5 of 186
55
The University of Texas Southwestern Medical Center
Dallas, United States
3 h-index
10 publications
1.8K citations
Austin Health
Melbourne, Australia
2 h-index
8 publications
239 citations
Burnet Institute
Melbourne, Australia
2 h-index
6 publications
203 citations
Janssen (United States)
Hopewell, United States
2 h-index
9 publications
272 citations
Amgen (United States)
Thousand Oaks, United States
2 h-index
24 publications
3.6K citations
University of Veterinary Medicine Vienna
Vienna, Austria
1 h-index
2 publications
30 citations
Carterra (United States)
Salt Lake City, United States
1 h-index
1 publications
30 citations
Tokyo Institute of Technology
Tokyo, Japan
1 h-index
2 publications
60 citations
1–8 of 55
JI · 4 publications · 670 citations
4
h-index
PEDS · 3 publications · 580 citations
3
h-index
3 publications · 81 citations
3
h-index
1 publications · 15 citations
1
h-index
1 publications · 197 citations
1
h-index
1–5